Research Presentation Sessions: Oncologic Imaging
RPS 1816 - Advances in MRI for oncological imaging
Lectures
1
Response evaluation of cancer therapeutics (RESPECT-MI) in metastatic breast cancer (MBC): preliminary data from a whole body magnetic resonance imaging (WB-MRI) study
07:00Roberta Maggioni, Veduggio Con Colzano / IT
2
MRI proton density fat fraction for estimation of tumour grade in steatotic hepatocellular carcinoma
07:00Darius Kurt, Bonn / DE
3
Impact of 18F-FDG PET/MRI on therapeutic management of women with newly diagnosed breast cancer: results from double-center trial
07:00Julian Kirchner, Dusseldorf / DE
4
The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma
07:00Jin Wang, Guangzhou / CN
5
Clinical impact of whole-body MRI as a problem solving tool in patients with high risk colorectal cancer
07:00Doenja Marina Johanna Lambregts, Amsterdam / NL
6
Diffusion-weighted MRI after radiofrequency ablation for hepatocellular carcinoma
07:00Heba Albalshy, shebin el-kom / EG
7
ADC measurement in whole body MRI for multiple myeloma: a three b-values vs. two b-values DWI comparison
07:00Marta Zerunian, Rome / IT
8
Is bone marrow fat fraction a surrogate of marrow cellularity? A quantitative whole spine T2 Dixon study
07:00Charbel Mourad, Beyrouth / LB
9
EMVI detection in locally advanced rectal cancer after pCRT with T2, DWI and contrast-enhanced sequences: a comparison
07:00Raimondo Angelone, Padua / IT
10
Correlation between MRI, surgical and pathological peritoneal cancer index for colorectal cancer patients undergoing cytoreductive surgery and HIPEC
07:00Doenja Marina Johanna Lambregts, Amsterdam / NL
11
Efficiency of diffusion tensor imaging in the diagnosis of prostate cancer
07:00Kanat Yessenkululy Karakoishin, Almaty / KZ
12
Moderation
00:00Heinz-Peter Schlemmer, Heidelberg / DE